Inventor

WIEDENMANN ALEXANDER

DE22 patents

⚠️ This page may combine multiple inventors who share the name “WIEDENMANN ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WIEDENMANN ALEXANDER

PIERIS PHARMACEUTICALS GMBH

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof

Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereof

Specific-binding polypeptides and uses thereof

Specific-binding polypeptides and uses thereof

Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof

Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof

Proteins specific for calcitonin gene-related peptide

Proteins specific for calcitonin gene-related peptide

Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)

Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response

Fusion molecules

Multi-specific polypeptide useful for localized tumor immunomodulation

Nucleic acid molecules encoding muteins of human lipocalin 2 with affinity for glypican-3 (GPC3)

SANOFI SA

Proteins specific for pyoverdine and pyochelin

Proteins specific for pyoverdine and pyochelin

Fusion molecules

Proteins specific for pyoverdine and pyochelin

Proteins specific for pyoverdine and pyochelin

Proteins specific for pyoverdine and pyochelin

DAIICHI SANKYO CO LTD

Nucleic acid molecules encoding muteins of human tear lipocalin which bind PCSK9

PIERIS AG

Human tear lipocalins which bind PCSK9 and methods of use thereof

PIERIS AUSTRALIA PTY LTD

Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2)